Aziyo Biologics Inc (AZYO)

NASDAQ
6.83
-0.27(-3.80%)
  • Volume:
    1,942
  • Day's Range:
    6.83 - 7.31
  • 52 wk Range:
    4.10 - 7.89

AZYO Overview

Prev. Close
7.1
Day's Range
6.83-7.31
Revenue
46.47M
Open
7
52 wk Range
4.1-7.89
EPS
-2.88
Volume
1,942
Market Cap
93.04M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,805
P/E Ratio
-2.54
Beta
0.505
1-Year Change
3.96%
Shares Outstanding
13,622,125
Next Earnings Date
Nov 24, 2022
What is your sentiment on Aziyo?
or
Market is currently closed. Voting is open during market hours.

Aziyo Biologics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade
  • Aziyo Biologics, Inc. Misses Q2 EPS by 13c
    • ByInvesting.com-

    Aziyo Biologics, Inc. (AZYO) reported Q2 EPS of ($0.69), $0.13 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $12.6 million versus the consensus...

Aziyo Biologics Inc Company Profile

Aziyo Biologics Inc Company Profile

Employees
157

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Read More

Analyst Price Target

Average10.50 (+53.73% Upside)
High13
Low8
Price6.83
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellNeutralSell
Technical IndicatorsStrong SellBuyBuyStrong BuyBuy
SummaryStrong SellNeutralNeutralBuyNeutral
  • Any thoughts?
    0